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ABSTRACT 
Fluid bed coating has been proposed in the past as an alternative technology for 
manufacturing of drug-polymer amorphous solid dispersions, or so-called glass solution. It 
has the advantage of being a one step process, and thus omitting separate drying steps, 
addition of excipients or manipulation of the dosage form. In search of an adequate sample 
preparation method for mDSC analysis of beads coated with glass solutions, glass 
transition broadening and decrease of the glass transition temperature was observed with 
increasing particle size of crushed coated beads and crushed isolated films of 
indomethacin and polyvinylpyrrolidone. Substituting indomethacin with naproxen gave 
comparable results. When ketoconazole was probed or the solvent in INDO-PVP films 
was switched to DCM or a methanol-DCM mixture, two distinct Tg regions were 
observed. Small particle sizes had a glass transition in the high Tg region, large particle 
sizes in the low Tg region. This particle size dependent glass transition was ascribed to 
different residual solvent amounts in the bulk and at the surface of the particles. A 
correlation was observed between the deviation of the glass transition temperature from 
that calculated from the Gordon-Taylor equation and the amount of residual solvent at the 
glass transition temperature of particles with different sizes. 
 
Keywords: Amorphous, Glass transition, Solid dispersion, Thermal analysis, 
Thermogravimetric analysis, Modulated differential scanning calorimetry, Residual 
solvent, Fluid bed coating, Rotary evaporation, Bead coating 
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List of abbreviations: 
API: active pharmaceutical ingredient 
DCM: dichloromethane 
DSC: differential scanning calorimetry 
INDO: indomethacin 
KETO: ketoconazole 
mDSC: modulated differential scanning calorimetry 
NAP: naproxen 
PVP: polyvinylpyrrolidone 
stdev: standard deviation 
Tg: glass transition temperature 
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1. INTRODUCTION 
Solid dispersions are considered to be one of the promising formulation strategies 
to increase the solubility and bioavailability of poorly soluble active pharmaceutical 
ingredients (API).1 Despite being reported for the first time over 40 years ago2, only a 
limited number of approved drug formulations are on the market today.3 While there are 
many subdivisions of solid dispersions, attention nowadays is focused on glass solutions 
where the drug is molecularly dispersed into an amorphous carrier (mostly polymers), 
resulting in a one phase system.4,5 Because solid dispersion manufacturing often leads to 
supersaturated glass solutions which are in thermodynamical non-equilibrium, risks of 
phase separation into drug rich and polymer rich regions are constantly present, which can 
ultimately lead to crystallization of the API and the subsequent loss of its solubility 
advantage.6 Phase separation risk can even be increased by absorption or adsorption of 
water from the environment, residual solvent or manipulations of the glass solutions into 
final dosage forms. 
In addition to spray drying as a well-established manufacturing procedure for glass 
solutions via the solvent method, fluid bed coating can be proposed as a viable alternative. 
As compared to spray drying, fluid bed coating is a largely unexplored manufacturing 
method and has numerous potential advantages. It allows the formulation to be dried 
immediately into the coating device. This is very important to remove residual solvents 
from the system, because these are often toxic and can cause unwanted plasticization of 
the system. Also, the coating of beads omits any additional processing steps, like milling 
or compression, to acquire a final dosage form. These additional processing steps have 
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been shown to lead to solid state changes, for example compression which induced 
amorphous-amorphous phase separation in spray dried solid dispersions.7 
Few studies have been previously reported in literature, mostly emphasizing on the 
solubility advantage of the solid dispersions prepared by coating in comparison with the 
pure drug substance. However, a thorough understanding of the physical structure and 
phase behavior is of the utmost importance for the estimation of the stability of the 
produced solid dispersions. To analyze this phase behavior, differential scanning 
calorimetry (DSC) is one of the tools of choice. It is able to detect the most important 
markers of instability in solid dispersions, namely amorphous-amorphous phase 
separation, enthalpic recovery of amorphous materials and the presence of crystalline API. 
Due to solid dispersions being multi-component systems and the production method, some 
transitions can overlap in a standard DSC. In modulated differential scanning calorimetry 
(mDSC), where the total heat flow can be mathematically separated (a deconvolution 
operation) into a reversing heat flow (a measure of the sample’s heat capacity) and a non-
reversing heat flow signal (heat flow associated with kinetic or kinetically controlled 
processes), these overlapping transitions can be clearly distinguished. For example, when 
preparing solid dispersions using the solvent evaporation method, some residual solvent 
can remain present in the system, upon evaporation due to heating in the DSC. This will 
be visible in the thermogram as a broad endotherm masking all other thermal events (glass 
transition). Due to the kinetic nature of solvent evaporation, this will be explicitly visible 
into the non-reversing heat flow signal in mDSC, provided a well optimized modulation 
program. 
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When glass solutions are produced, they are monophasic systems which will show 
one single glass transition, showing full miscibility of polymer and API. One of the most 
commonly used ways to calculate this mix-Tg is by using the Gordon-Taylor equation8: 
௚ܶ ൌ ௪భ ೒்భା௞ಸ೅ሺଵି௪భሻ ೒்మ௪భା௞ಸ೅ሺଵି௪భሻ       (equation 1) 
In this equation: Tg1≤ Tg2 so Tg1 usually represents the glass transition of the drug and Tg2 
the glass transition of the polymer. w is the weigth fraction and the constant kୋ୘ ൌ
ఘభ∆ఈభ
ఘమ∆ఈమ ൎ
ఘభ ೒்భ
ఘమ ೒்మ 
9, where ρ is the density of the component and Δα the change in thermal 
expansivity of the component at Tg .10 
In previously performed studies involving coated solid dispersions onto inert 
carriers, a lot of variation is seen in methodology of DSC/mDSC analysis. Hsiu-O et al.11 
and Zhang et al.12 performed DSC analysis with the coated pellets loaded as such into the 
aluminium pans. Sun et al. did not analyze the produced solid dispersions with DSC.13 In 
the study of Li et al. solid dispersion samples were prepared by spraying into the drying 
chamber without sugar pellets under the same coating conditions, and then the solid 
dispersions were peeled off carefully and ground to a fine powder for DSC analysis.14 
Nikowitz et al. did not specify any DSC sample preparation method in their paper about 
the study of recrystallization in coated pellets.15 Lastly, in a recent study of Mahmoudi et 
al. amorphous solid drug dispersions were prepared via either rotary evaporation or fluid 
bed drug layering. Only powder samples from the rotary evaporation were analyzed by 
DSC.16 
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The aim of this study is to develop a reliable mDSC method for glass solutions, 
coated on an inert carrier, and the investigation of an interesting glass transition 
phenomenon associated with this method development. 
Naproxen (NAP), indomethacin (INDO) and ketoconazole (KETO) were used as 
model drugs. Polyvinylpyrrolidone (PVP) K25 was selected as a model hydrophilic 
polymer. NAP and INDO both have hydrogen donors which can form hydrogen bonds 
with PVP, whereas KETO is unable to form hydrogen bonds with the polymer. NAP-PVP 
and INDO-PVP are well known solid dispersion systems which have been extensively 
studied in the past.17-21  
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2. MATERIALS AND METHODS 
2.1 Materials 
Naproxen and Indomethacin were purchased from FAGRON Ltd. (Waregem, 
Belgium), ketoconazole was a kind gift from Janssen Pharmaceutica (Beerse, Belgium), 
polyvinylpyrrolidone K 25 was a generous gift from BASF (Ludwigshafen, Germany). 
Sugar spheres (diameter 710 - 850 µm) were kindly donated by Hanns G. Werner GmbH 
(Tornesch, Germany). 
2.2 Methods 
2.2.1 Fluidized bed coating 
A 30-70% IND-PVP (1:2 weight ratio to beads) glass solution was coated onto 
500g of beads from a 6.67% (w/v) ethanol solution, using bottom spray fluid bed coating.  
The sugar spheres were loaded into the preheated coating chamber of an Aeromatic 
MP 1 multiprocessor (GEA, Switzerland). The sugar beads were heated for half an hour. 
The drug-polymer solution was coated onto the sugar beads using a bottom spray set-up 
with a Würster insert. When the spraying was finished, the pellets were dried until 
immobilization due to electrostatic charges. The coated spheres where unloaded, weighed 
and dried for an additional 48 hours in an oven at 40°C. 
In the formation of the INDO-PVP beads, the air volume was set at 1566.3L/min, 
inlet temperature was 50°C, atomizing air pressure 1.5 bar and the feed rate was 6 ml/min.  
After 48 hours of drying in a hot air oven at 40°C, sugar beads were crushed with a 
pestle in a mortar and sieved into different particle size ranges. 
2.2.2 Film formation by rotary evaporation 
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Glass solution films were made using a Büchi Rotavapor R-210 (Flawil, 
Switzerland). API-polymer (30-70% w-w) was dissolved into a common solvent (ethanol, 
Dichloromethane (DCM) or a 1:1 (v/v) mixture of DCM and methanol) to form a 10% 
(w/v) solution. The water bath was set to 60°C for ethanol solutions and 40°C for DCM 
and DCM-methanol solutions. A round bottom flask with the solution was rotated into the 
water bath under vacuum. After formation of a film, the glass solution was dried for an 
additional 48 hours in an oven at 40°C. In accordance with the coated beads, the films 
were crushed and sieved in different particle size ranges for analysis. 
2.2.3 Modulated temperature differential scanning calorimetry (mDSC) 
 mDSC measurements were carried out with a TA instruments Q2000 modulated 
DSC (Leatherhead, UK) equipped with a refrigerated cooling system (RCS90). During 
analysis, the DSC cell was purged with a nitrogen flow of 50 ml/min. Mathematical 
analysis of the data was performed using TA Instruments Universal Analysis software 
(version 4.4, Leatherhead, UK). TA Instruments standard aluminium pans (Brussels, 
Belgium) were used for all measurements. Glass transition temperatures were measured at 
half height in the reversing heat flow. The step jump in heat capacity observed in the 
reversing heat flow signal was further examined in the corresponding derivative signal 
after Savitsky-Golay smoothing with points of window set at 20. The first derivative of the 
reversing heat flow was chosen to visualize the glass transitions because discrete changes 
are much better visible in the peaks of the derivative reversing heat flow, as compared 
with the small baseline shifts of the original reversing heat flow. 
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 Octadecane and indium were used to calibrate the DSC temperature scale, the 
enthalpic response was calibrated with indium. The heat capacity was calibrated using 
sapphire disks.  
All sample masses were between 4-7 mg (accurately weighed). The samples were 
kept isothermal at 40°C for 60 minutes, followed by heating from 40°C to 180°C (or 0-
200°C depending on the experiment) for the glass solution films and 0°C to 165°C for the 
coated beads. A heating rate of 2°C/min was applied with a temperature modulation of 
0.636°C every 40s. All samples were measured in duplicate. 
2.2.4 Thermo gravimetric Analysis 
The prepared samples (coated beads and films, crushed and sieved) were analyzed 
using a TA instruments SDT Q600 (Leatherhead, UK) to determine moisture and volatile 
contents. The samples were heated at 5°C/min from 25 °C to 150 °C in a continuous mode 
in a first type of experiment. In the second type of experiment, samples were kept 
isothermal at 50°C for 20 hours, heated to 140°C at 10°C/min and kept isothermal for 2 
hours, and finally cooled again to 50°C at 10°C/min and kept isothermal for 1 hour. 
Finally, in a third experiment samples were kept isothermal at 40°C for 1 hour and 
subsequently heated at 2°C per minute to 170°C. A dry N2 purge of 100 mL/min was used 
to be able to maintain an inert environment. Weight loss due to solvent and moisture 
evaporation was calculated as percentage weight loss compared to the original sample 
mass. Sample masses are between 10 and 20 mg (accurately weighed). 
11 
 
3. RESULTS AND DISCUSSION 
3.1 mDSC analysis of INDO-PVP (30/70% w/w) glass solutions, coated onto 
sugar beads 
As mentioned above, no universally applicable sample preparation method exists 
for the DSC analysis of coated beads. In search of effective sample preparation for mDSC 
analysis, the bottom of a DSC pan was filled with coated beads and analyzed. This 
approach produced no visible signal other than the melting peak of sucrose. It was clear 
that the contact area between the coating and the bottom of the pan was insufficient. In a 
second attempt, beads were crushed to improve thermal contact. However, the only visible 
transition was the melting of the sucrose beads, leading to the observation that there was, 
proportionally, too much sucrose present. In a next step, beads were crushed gently with a 
pestle and mortar and sieved to separate different particle sizes in an attempt to find a 
specific particle size range where more coating was present relative to the sucrose content. 
This sieving was performed using seven sieves (pore diameter: 32µm, 63µm, 90µm, 
150µm, 250µm and 355µm). After sieving for an adequate time the material on top was 
discarded (larger than 355µm), the other material was collected and stored separately for 
each particle size range. Subsequently, six different particle size ranges were stored in 
closed containers: 0-32µm, 32-63µm, 63-90µm, 90-150µm, 150-250µm and 250-355µm. 
Figure 1 shows the first derivate of the reversing heat flow in function of temperature for 
the different particle sizes of crushed and sieved INDO-PVP beads. 
 Surprisingly, the data show a shift and broadening of the glass transition region 
with increasing particle size. Table 1 lists the numerical values of the mean glass transition 
onset, offset, range and half-height temperature of 3 replicate experiments. 
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There is a difference of 26.2°C between mean glass transition temperature of the 
smallest and largest particle size range. The glass transition range has also increased with 
ca. 18°C, which means the mean width has become more than doubled, hence a large 
broadening of the glass transition region.  
This glass transition shift is probably also the reason why it only becomes visible 
in DSC after sieving. When the beads are only crushed, there is a large particle size variety 
present, so the sample will have multiple small glass transitions which will lead to a very 
broad signal in the reversing heat flow, which is not detectable by mDSC. 
3.2 mDSC analysis of INDO-PVP (30/70% w/w) glass solution films 
To confirm this particle size induced glass transition temperature decrease and 
broadening in a more simple formulation, INDO-PVP films were made by rotary 
evaporation. In essence, this is the way the glass solutions are formed on the sucrose beads 
during fluid bed coating. Droplets form miniature films around the inert carrier and are 
dried during cycling in the fluidized bed. When reentering the Würster insert and being 
sprayed upon, this process repeats itself. Derivative reversing heat flow signals in function 
of temperature for the different particle size ranges are shown in Figure 2 for a first and 
second heating cycle. After the first heating cycle is completed, the sample is cooled at 
maximum capacity of the Q2000 DSC (around 30°C/min). After temperature equilibration 
at 0°C the second heating cycle is initiated with the same heating rate and modulation 
parameters used during first heating. 
All numerical information about the glass transition is given in Table 2. From the 
INDO-PVP films, it’s also evident that Tg shifts to lower temperatures and broadens as the 
particle size increases. There is an 18.4°C difference in temperature shift and a 16.6°C 
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broadening between the values of the smallest and largest particle size. These differences 
disappear respectively to 3.6°C and 1.9°C when the sample is cooled and reheated. 
The dependence of the glass transition temperature on the particle size has, to the 
best of our knowledge, never been reported before. Contrary to the well-known melting 
point depression related to particle size reduction22, there is no fundamental physical 
phenomenon known to explain the dependence of the glass transition temperature on the 
particle size.21 The trend observed in the coated beads was thus confirmed and even more 
pronounced in the glass solution films. Furthermore, when samples are cooled and 
reheated in the mDSC, all differences virtually disappear. These observations lead to two 
possible explanations. First, there can be a difference in mixing for different particle sizes. 
When a particle with a larger size would have a higher ratio of indomethacin compared to 
the particles with smaller size, the glass transition would be lower. This could be seen as 
different phases in different particle sizes. However, this would be highly unlikely because 
the films are prepared from a solution where drug and polymer are fully dissolved. It is 
evenly unlikely that these different drug-polymer ratios are induced while crushing the 
films or beads because the samples are crushed with the same intensity and during the 
same amount of time. A second hypothesis can be proposed where different particle sizes 
have different amounts of residual solvents, which can act as a plasticizer and thus cause a 
decrease in glass transition temperature of the system.  
The heat-cool-heat experiment cannot exclude one of the hypotheses. Residual 
solvent will be completely removed when heating up to 180°C and plasticizing effects of 
these solvents will be eliminated when the sample is reheated. However heating above the 
glass transition also increases the mobility of the (amorphous) drug and polymer, which 
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can affect the mixing of drug and polymer, also eliminating the observed differences in the 
first heating step. 
Previous studies provide the data to calculate the glass transition temperature of 
glass solutions with the Gordon-Taylor equation for this drug-polymer system. Glass 
transition temperature (430 K) and density (1.14 g/cm³) for PVP K25 are taken from 
Paudel et al.17, glass transition temperature (315 K) and density (1.31 g/cm³) of 
indomethacin from Matsumoto and Zografi21. Calculation yielded a glass transition 
temperature of the glass solution of 118°C. Glass transitions of the second heating cycles 
are closest to this ideal mixing Tg. The reason is of course that in the second heating cycle 
most of the residual solvents (which act as plasticizer) are eliminated from the glass 
solutions and not that the system is approaching ideal behavior (as the values are close to 
those calculated from the Gordon-Taylor equation in the second heating cycle). When 
considering the first heating cycle, particles with the smallest size have a glass transition 
temperature closest to 118°C, which points out that at the glass transition, the smallest 
particles contain the least residual solvent. 
Different observations were made when the same film fragments, divided in 
different size ranges, were stored at room temperature for 7 weeks and reanalyzed with 
mDSC. The thermograms of the different particle size ranges are shown in Figure 3. The 
observed glass transition shift observed in the initial thermogram, has now disappeared. 
Only the particles with the largest size still show a decrease in Tg. 
Storage at room temperature can enable the samples to further dry and get rid of 
the residual solvents, but storage at room temperature, which is far below the glass 
transition temperature of the glass solutions, does not provide the necessary mobility to 
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spontaneously induce mixing of the systems. It can be reasonably assumed that larger 
particles, which have a much smaller surface area to mass ratio, and thus contact surface 
with the surroundings (air), need a longer time to lose their residual solvent. This is the 
reason why the particles with the largest size range still have a decreased glass transition 
temperature. This experiment thus reinforces the residual solvent hypothesis. 
3.3 mDSC analysis of glass solution films of Naproxen-PVP and 
Ketoconazole-PVP (30-70% w-w) 
In order to confirm the generality of the observed phenomenon, systems with a 
different API (Naproxen and Ketoconazole) were selected and compared with the same 
polymer and in the same ratio to solely investigate the influence of changing the active 
component. Ketoconazole was chosen because, contrary to INDO and NAP, it doesn’t 
have any hydrogen donor groups and is thus unable to form hydrogen bonds with PVP. 
Figure 4 shows the derivative of the reversing heat flow for NAP-PVP (30-70% w/w) and 
KETO-PVP (30-70% w/w) in function of temperature for 5 different particle size ranges. 
The different particle sizes for the NAP-PVP glass solution again show a distinct 
glass transition decrease for increasing particle size, although this decrease is mainly 
observed between the two smallest particle sizes, further decrease is more discrete. KETO-
PVP shows a different pattern, as in these glass solution particles, two different glass 
transition regions can be distinguished. Particles with smaller sizes (0-32µm and 32-
63µm) predominantly reside in the high Tg region, around 115-120°C. Particles with 
larger sizes (150-250µm and 250-355µm) are mainly in the low Tg region, around 60-
70°C. The particles with an intermediate size range (between 63-90µm) have two Tg 
peaks, one in each region. 
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While the NAP-PVP samples confirmed the trend observed with the INDO-PVP 
samples, KETO-PVP showed a slightly different behavior, though still a particle size 
dependent glass transition temperature.  
For the calculation of the Gordon-Taylor equation, glass transition temperature 
(279K) and density (1.25 g/cm³) of naproxen are taken from Paudel et al.17 and Tg 
(317.5K) and density (1.30g/cm³) of ketoconazole from Van den Mooter et al.23 Glass 
transition temperature for naproxen is calculated at 100°C and for ketoconazole at 119°C. 
It is again obvious that glass transitions from the smallest particles are closest to the 
calculated mixing Tg, thus reinforcing again the role of the available surface area for 
solvent evaporation. 
3.4 mDSC analysis of INDO-PVP (30/70% w/w) glass solution films from a 
10% (w/v) DCM and DCM-methanol (50-50% v-v) solution 
To investigate the influence of different solvents on the phase behavior and 
resulting glass transition decrease with particle size, ethanol as solvent was replaced by 
dichloromethane and a 1:1 mixture of dichloromethane and methanol. For the pure DCM 5 
particle size ranges up to 250µm were tested, for the DCM-methanol mixture 7 particle 
size ranges were tested, up to 425µm. Figure 5 represents the derivative reversing heat 
flow in function of temperature for the different particle size ranges of DCM (A) and 
DCM-methanol (B). 
With the change of solvent, the same phenomenon was observed as in the KETO-
PVP glass solutions, produced from an ethanol solution. For DCM as well as DCM-
methanol, a distinction can again be made between a high Tg region with predominantly 
the particles with smaller size ranges on one hand, and a low Tg region with the particles 
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with larger size ranges on the other hand. Intermediate particle size ranges again show a 
glass transition in the high Tg region as well as in the low Tg region. These experiments 
show the separation in Tg regions is not a phenomenon that can be solely described to 
KETO-PVP, but something as simple as a change in solvent can induce this separation. 
3.5 TGA analysis of INDO-PVP (30-70% w-w) glass solution films 
To be able to take into account the role of the residual solvent, present in the film 
particles, and/or the amount of absorbed water from the environment into the particles, 
TGA analysis was performed on all of the particle size ranges. Table 3 represents the 
average weight loss of different particle size ranges of INDO-PVP using a heating 
program of 5°C/min from 25°C to 150°C. These experiments clearly show a more or less 
equal amount of solvent in particles of a different size range. This seems to disprove the 
solvent hypothesis. However, a second TGA analysis was performed on 3 particle sizes of 
the INDO-PVP films, to differentiate between weight loss sub-Tg (50°C) and above-Tg 
(140°C). Figure 6 represents the weight (%) and temperature (°C) in function of time 
(min) for 0-32µm, 90-150µm and 250-355µm particles. 
In the first isothermal step at 50°C, the smaller the particles, the more weight is 
lost due to evaporation of residual solvent, which can be explained by its higher surface 
area to mass ratio. Despite being dried for 20 hours, all particle size samples still contain 
residual solvent, which isn’t released before heating above the glass transition 
temperature. After completion of the experiment, particles in the range between 90-150µm 
and 250-355µm have lost almost exactly the same mass, the 0-32µm particle size range is 
only slightly higher. 
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These findings lead to the conclusion that there is a difference in residual solvent 
amount, but specifications need to be made. The glass transition shift with increasing 
particle size range is a result of differences in sub-Tg residual solvent evaporation. Due to 
the much higher surface area to mass ratio of the small particle size ranges, residual 
solvent can evaporate to a higher extent than from the particles with larger size ranges, 
where more bulk solvent will be present. When looking at mDSC thermograms with two 
distinct Tg regions, the high Tg region can be represented by the glass transition of the 
solvent poor surface of the film particles and the low Tg region by the solvent ‘rich’ bulk 
of the film particles. Gradually shifting of the glass transition can be seen as a more 
discrete transition than separation into two distinct Tg regions. These differences can be 
achieved during heating in the DSC cell or during the isothermal step of 40°C for 1 hour, 
programmed before every run. The fact that this glass transition decrease has disappeared 
after 7 weeks also supports this hypothesis because here the residual solvent could have 
had enough time to evaporate, except in the largest particle size range where a Tg decrease 
is still visible. These findings can shine another light on DSC experiments of solid 
dispersions, prepared by solvent methods like for instance spray drying, which may 
contain a very broad range of particle sizes. When  only DSC analysis is performed on 
particles with an intermediate particle size range (see Figures 4 and 5), two glass 
transitions may theoretically be observed and falsely interpreted as a phase separated 
system, which in reality really are particles with different solvent poor surface/solvent rich 
bulk ratios. The broadening and gradual shift of glass transitions has already been reported 
before.24 In this article, this shift and broadening is a result of moisture sorption, which 
results in a depressed Tg in the outer layers of glassy maltodextrin particles. It can be 
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stated that this effect is in fact a similar phenomenon of what was observed in this article 
but in the opposite direction. 
In an attempt to prove the residual solvent hypothesis, a third TGA experiment was 
performed where the heating method was equal to the mDSC method, namely an 
isothermal step at 40°C for 1 hour and subsequently a heating step of 2°C/min to 170°C. 
When simultaneously performing these TGA and mDSC experiments on a freshly 
prepared INDO-PVP (30-70% w/w) film (from a 10% ethanol solution w/v), which was 
crushed and separated into different particle size ranges, it was possible to determine the 
exact residual solvent amount at the glass transition temperature of the different size 
ranges. Glass transition temperatures were determined in the mDSC experiment. 
Previously, the glass transition temperature of INDO-PVP (30-70% w/w) had been 
calculated using the Gordon-Taylor equation and was 118°C. From this temperature, we 
can calculate the deviation for each particle size range. This is described in Table 4 
together with the solvent loss from the glass transition temperature to 170°C for each 
particle size range. When the deviation from the Gordon-Taylor temperature is put in 
function of the solvent loss from Tg to 170°C, a correlation can be found, this is 
represented in Figure 7. As can be seen from Figure 7, the correlation has a good fit (R²= 
0.983). This indicates that the glass transition temperature decrease with increasing 
particle size is a result of the presence of the amount of residual solvent at the glass 
transition temperature, and not of the total amount of residual solvent. The glass transition 
temperature decrease is not in correspondence with the total amount of residual solvent 
because of the different evaporation rates, due to the different surface area to mass ratio’s, 
discussed in the previous TGA experiment. This evaporation is an imminent consequence 
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of the manner in which DSC measures the glass transition temperature, namely by heating 
up the sample. When performing (m)DSC analysis on glass solutions, prepared by the 
solvent method, caution is necessary when interpreting glass transitions from particles 
with wide particle size ranges.  
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4. CONCLUSION 
In search of a suitable mDSC sample preparation method for glass solutions of 
INDO-PVP, coated on inert carriers, an interesting phenomenon arised. When crushed and 
sieved into different particle size ranges, glass transitions of the coated beads shifted to 
lower temperatures and broadened with increasing particle size range. These findings were 
confirmed for INDO-PVP films prepared by rotary evaporation. Substituting indomethacin 
with naproxen gave comparable results. When the API was ketoconazole and the solvent 
in INDO-PVP films was switched to DCM or a methanol-DCM mixture, two distinct Tg 
regions were observed. Small particle sizes had a glass transition in the high Tg region, 
large particle sizes in the low Tg region. TGA experiments showed that, while total mass 
loss due to residual solvent evaporation for all particle sizes are more or less the same, 
there is a distinct difference for sub Tg and above Tg mass loss, due to huge differences in 
surface area to mass ratio. Differences in glass transition for different particle size ranges 
can be ascribed to differences in solvent-free surface and solvent-rich bulk ratios. A 
correlation was found between the solvent loss from the glass transition temperature on 
and the deviation from the Gordon-Taylor derived glass transition temperature for the 
different particle size ranges. This further indicates that the glass transition decrease in 
glass solution particles with increasing particle size is due to the amount of residual 
solvent present at the glass transition temperature of the particles. 
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Table 1: Mean glass transition onset, offset, range and half-height temperature of different 
particle size ranges of INDO-PVP coatings onto sucrose beads (n=3). 
n=3 Glass transition temperature (°C) 
Particle size (µm) Onset Offset Range Half Height St dev Half Height 
0-32 105,9 122,6 16,7 114,2 0,7 
32-63 104,8 121,2 16,4 113,0 0,8 
63-90 101,8 123,3 21,5 112,4 2,9 
90-150 84,1 116,0 31,9 100,0 0,4 
150-250 69,3 108,6 39,3 89,1 2,2 
250-355 70,4 105,4 34,9 88,0 0,2 
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Table2: Mean glass transition onset, offset, range and half-height temperature of different 
particle size ranges of INDO-PVP films in first and second heating cycle (n=3). 
n=3 Glass transition temperature (°C) 
1st heating cycle 
     
Particle size (µm) Onset Offset Range Half Height St dev Half Height 
0-32 104,0 118,7 14,7 111,3 0,1 
32-63 101,6 119,6 18,0 108,9 1,0 
63-90 94,4 116,3 21,8 105,4 0,6 
90-150 87,3 113,8 26,5 100,6 0,3 
150-250 77,2 108,5 31,3 93,0 0,6 
2nd heating cycle 
     
Particle size (µm) Onset Offset Range Half Height St dev Half Height 
0-32 107,3 123,1 15,9 115,2 0,6 
32-63 107,7 123,2 15,4 115,5 0,1 
63-90 106,8 122,9 16,0 114,8 0,3 
90-150 105,9 122,3 16,3 114,0 0,4 
150-250 102,8 120,5 17,7 111,6 0,0 
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Table 3: weight loss (%) for different particle size ranges of INDO-PVP film 
INDO-PVP FILMS sample 1 sample 2 MEAN 
Particle size (µm) Weight loss (%) Weight loss (%) Weight loss (%)
0-32 3,877 4,793 4,335 
32-63 4,488 4,280 4,384 
63-90 4,565 4,431 4,498 
90-150 3,983 4,157 4,070 
150-250 4,690 4,220 4,455 
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Table 4: Weight loss from the glass transition temperature (%) and Gordon-Taylor Tg 
temperature depression (%) for the different particle size ranges of INDO-PVP film 
INDO-PVP FILM (30-70% w/w) 
Particle size 
(µm) 
Solvent loss from Tg to 
170°C (%) 
Gordon-Taylor Tg temperature 
depression (%) 
0-32 1,35 95,29 
32-63 1,86 87,40 
63-90 2,21 84,54 
90-150 2,51 78,07 
150-250 2,74 77,65 
250-355 3,15 70,77 
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Figure 1: Derivative reversing heat flow in function of temperature for different particle 
size ranges of crushed and sieved INDO-PVP (30/70% w/w) coated sucrose beads. 
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Figure 2: Derivative reversing heat flow in function of temperature for INDO-PVP films 
in the first 5 (A) and second (B) heating cycle for different particle sizes. 
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Figure 3: Derivative reversing heat flow in function of temperature for different particle 
size INDO-PVP films after storage at room temperature for 7 weeks. 
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Figure 4: Derivative reversing heat flow thermogram of NAP-PVP (A) and KETO-PVP 
(B) for 5 different particle sizes. 
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Figure 5: Derivative heat flow in function of temperature for the different particle size 
ranges of a INDO-PVP glass solution film, prepared from a  DCM (A) and DCM-
Methanol (B) solution. 
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Figure 6: Weight (%, green line) and temperature (°C, blue line)in function of time (min) 
for INDO-PVP film particles with a size range of 0-32µm, 90-150µm and 250-355µm. 
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Figure 7: Depression on the Gordon-Taylor glass transition temperature in function of 
solvent loss from the glass transition to 170°C for all different particle size ranges, with 
trendline and R² value. 
 
